Indoco Remedies announced today that the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) inspected its solid dosages manufacturing facility in Goa (Plant I) from 07 September to 09 September 2026. The UK-MHRA current Good Manufacturing Practices (cGMP) inspection concluded with no critical or major observations.
Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.